Nexalin Technology, Inc. SEC filings NXL

Nexalin Technology, Inc. has 204 filings in SEC EDGAR's recent list, going back to Aug 9, 2011. Its latest annual report, Form ARS, was filed on Jul 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (other events). The company's fiscal year ends on December 31.

Nexalin Technology, Inc. SEC filings
Form Description Filed Period
PRE 14A Preliminary proxy statement Oct 27, 2026 Oct 26, 2026
DEF 14A Proxy statement Jul 10, 2026 Aug 11, 2026
PRE 14A Preliminary proxy statement Jun 29, 2026 Jun 29, 2026
DEF 14A Proxy statement Jun 17, 2025 Jul 15, 2025
DEF 14A Proxy statement Jul 29, 2024 Aug 26, 2024
DEF 14A Proxy statement Jan 17, 2024 Mar 7, 2024
DEF 14A Proxy statement Oct 6, 2023 Nov 10, 2023

Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NXL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
, Emerging growth company
SEC CIK
1527352

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.